Cleared Traditional

K241613 - Elecrtronic Blood Pressure Monitor (BP-201

K241613 is an FDA 510(k) clearance for Elecrtronic Blood Pressure Monitor (BP-201, manufactured by Shenzhen Hbcare Technology Co.,Ltd. The device is a Class 2 Cardiovascular device with product code DXN cleared through the Traditional 510(k) pathway after a 133-day FDA review.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Oct 2024
Decision
133d
Days
Class 2
Risk

K241613 is an FDA 510(k) clearance for the Elecrtronic Blood Pressure Monitor (BP-201, BP-202, BP-203, BP-204, BP-205, B.... Classified as System, Measurement, Blood-pressure, Non-invasive (product code DXN), Class II - Special Controls.

Submitted by Shenzhen Hbcare Technology Co.,Ltd (Shenzhen, CN). The FDA issued a Cleared decision on October 16, 2024 after a review of 133 days - within the typical 510(k) review window.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.1130 - the FDA cardiovascular device oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Cardiovascular review framework, consistent with the majority of Class II 510(k) submissions.

View all Shenzhen Hbcare Technology Co.,Ltd devices

FDA 510(k) Submission Details - K241613

510(k) Number K241613 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received June 05, 2024
Decision Date October 16, 2024
Days to Decision 133 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
8d slower than avg
Panel avg: 125d · This submission: 133d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

DXN Device Classification - Class 2, Special Controls

Product Code DXN System, Measurement, Blood-pressure, Non-invasive
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.1130
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Peers - DXN System, Measurement, Blood-pressure, Non-invasive

All 566
Devices cleared under the same product code (DXN) and FDA review panel - the closest regulatory comparables to K241613.
Arm Blood Pressure Monitor (model: BPM-A7VL)
K243118 · Shenzhen Imdk Medical Technology Co., Ltd. · Nov 2024
Upper Arm Electronic Blood Pressure Monitor (U86E and TelliBP01)
K241007 · Shenzhen Urion Technology Co., Ltd. · Oct 2024
Arm Type Blood Pressure Monitor (BPM82)
K242193 · Avita Corporation · Oct 2024
Upper Arm Electronic Blood Pressure Monitor (FC-BP103, FC-BP106, FC-BP113, FC-BP120, FC-BP121, FC-BP130, FC-BP131)
K242721 · Shenzhen Finicare Co., Ltd. · Oct 2024
Blood Pressure Monitor (TMB-2092-G)
K241351 · Guangdong Transtek Medical Electronics Co., Ltd. · Aug 2024
Upper Arm Electronic Blood Pressure Monitor
K241129 · Shenzhen Goodlymed Technology Co., Ltd. · Jul 2024